Evidence map›Paper›PMID 39962266›Full record

ArticleNature2025

Author Correction: FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions.

Pablo Alcón, Artur P Kaczmarczyk, Korak Kumar Ray, Themistoklis Liolios, Guillaume Guilbaud, Tamara Sijacki, Yichao Shen, Stephen H McLaughlin, Julian E Sale, Puck Knipscheer and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Pablo AlcónMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0002-7435-3859
Artur P KaczmarczykDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-2100-2780
Korak Kumar RayDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-5390-698X
Themistoklis LioliosOncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands.
Guillaume GuilbaudMRC Laboratory of Molecular Biology, Cambridge, UK.
Tamara SijackiMRC Laboratory of Molecular Biology, Cambridge, UK.
Yichao ShenMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0009-0002-8601-1079
Stephen H McLaughlinMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0001-9135-6253
Julian E SaleMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0002-5031-3780
Puck KnipscheerOncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4198-0132
David S RuedaDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. david.rueda@imperial.ac.uk.ORCID http://orcid.org/0000-0003-4657-6323
Lori A PassmoreMRC Laboratory of Molecular Biology, Cambridge, UK. passmore@mrc-lmb.cam.ac.uk.ORCID http://orcid.org/0000-0003-1815-3710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39962266
PMCPMC11882437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.